Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
DALLAS, Feb. 06, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
Related news for (MDAI)
- Today’s Top Performers: MoBot’s Market Review 06/30/25 03:00 PM
- Spectral AI Announces Submission to FDA of its DeepView® System
- 24/7 Market News Snapshot 30 June, 2025 – Spectral AI, Inc. Class A Common Stock (NASDAQ:MDAI)
- Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer
- Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders